PUSCEDDU, VALERIA
 Distribuzione geografica
Continente #
EU - Europa 39.609
NA - Nord America 2.703
AS - Asia 1.547
SA - Sud America 252
Continente sconosciuto - Info sul continente non disponibili 149
AF - Africa 57
OC - Oceania 4
Totale 44.321
Nazione #
IT - Italia 35.828
NL - Olanda 3.192
US - Stati Uniti d'America 2.608
SG - Singapore 657
CN - Cina 443
BR - Brasile 190
VN - Vietnam 170
SE - Svezia 134
FR - Francia 101
DE - Germania 82
GB - Regno Unito 69
FI - Finlandia 56
HK - Hong Kong 55
IN - India 47
CA - Canada 45
UA - Ucraina 33
BD - Bangladesh 32
KR - Corea 23
ES - Italia 22
MX - Messico 22
PL - Polonia 19
ZA - Sudafrica 17
IQ - Iraq 16
RU - Federazione Russa 15
AR - Argentina 14
EC - Ecuador 14
AT - Austria 12
CO - Colombia 12
ID - Indonesia 11
BE - Belgio 10
TR - Turchia 10
IL - Israele 9
IR - Iran 9
SC - Seychelles 9
VE - Venezuela 9
JP - Giappone 8
PK - Pakistan 8
CR - Costa Rica 7
IE - Irlanda 7
MA - Marocco 7
SA - Arabia Saudita 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 5
KE - Kenya 5
KG - Kirghizistan 5
TN - Tunisia 5
TT - Trinidad e Tobago 5
AU - Australia 4
GR - Grecia 4
LT - Lituania 4
MK - Macedonia 4
MY - Malesia 4
PE - Perù 4
PH - Filippine 4
PY - Paraguay 4
TH - Thailandia 4
CL - Cile 3
CW - ???statistics.table.value.countryCode.CW??? 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
GT - Guatemala 3
HN - Honduras 3
NP - Nepal 3
RS - Serbia 3
SV - El Salvador 3
BO - Bolivia 2
EG - Egitto 2
GA - Gabon 2
HU - Ungheria 2
LU - Lussemburgo 2
NG - Nigeria 2
NI - Nicaragua 2
NO - Norvegia 2
OM - Oman 2
PT - Portogallo 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BJ - Benin 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GP - Guadalupe 1
HR - Croazia 1
JM - Giamaica 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LY - Libia 1
MN - Mongolia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
UG - Uganda 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 44.176
Città #
Cagliari 34.643
Amsterdam 3.181
Uta 911
Singapore 389
Ashburn 378
Dallas 284
San Jose 225
Council Bluffs 117
Boardman 98
New York 87
Beijing 84
Los Angeles 75
Nyköping 70
Fairfield 69
Chandler 65
Santa Clara 52
Hong Kong 49
The Dalles 48
Ho Chi Minh City 47
Helsinki 46
Houston 42
Wilmington 37
Seattle 36
Woodbridge 36
Hanoi 35
Hefei 34
Dearborn 31
Orem 26
Shanghai 26
Chicago 25
Rome 25
Lauterbourg 23
Milan 23
Seoul 23
Nanjing 22
São Paulo 22
Buffalo 20
Guangzhou 20
Boston 19
Cambridge 19
Columbus 19
Munich 18
Montreal 17
Dong Ket 16
Jacksonville 16
Redondo Beach 16
Frankfurt am Main 15
Ann Arbor 14
Chennai 14
London 14
Nuremberg 14
Phoenix 13
Shenzhen 13
Brooklyn 12
Düsseldorf 12
Atlanta 11
San Diego 11
Poplar 10
Zhengzhou 10
Denver 9
Johannesburg 9
Pune 9
Stockholm 9
Warsaw 9
Dublin 8
Haiphong 8
Hangzhou 7
Lappeenranta 7
Birmingham 6
Biên Hòa 6
Guayaquil 6
Jiaxing 6
Leawood 6
San José 6
Selargius 6
Tashkent 6
Toronto 6
Baghdad 5
Bishkek 5
Brussels 5
Florence 5
Mexico City 5
Nairobi 5
Nanchang 5
New Delhi 5
Olbia 5
Portsmouth 5
Quito 5
Salt Lake City 5
San Francisco 5
Shenyang 5
Turin 5
Bari 4
Belo Horizonte 4
Bexley 4
Changsha 4
Charlotte 4
Dubai 4
Jinan 4
La Maddalena 4
Totale 41.963
Nome #
BRAF-mutant colorectal cancer, a different breed evolving 3.259
Molecular-biology-driven treatment for metastatic colorectal cancer 2.795
The Osteological Collection of the University of Cagliari: From Early Neolithic to Modern Age 2.670
Thyroid dysfunction in disguise and treatment-related fatigue in the spotlight among metastatic colorectal cancer patients receiving regorafenib: Implications for clinical management. 2.663
Le collezioni scheletriche umane di epoca Nuragica dell'Università di Cagliari: sintesi delle conoscenze e nuovi dati paleobiologici 2.540
Sepolture tardo puniche dal lotto 7 di Tuvixeddu: due storie di bambini mai nati e alcune osservazioni epigrafiche. 2.504
Le collezioni scheletriche umane di epoca nuragica dell’Università di Cagliari: sintesi delle conoscenze e nuovi dati paleobiologici 2.448
Necropoli di Cannas di Sotto, Carbonia. Lo scavo della tomba 12. Notizia preliminare 2.343
Prognostic Value of Thyroid Hormone Ratios in Patients With Advanced Metastatic Colorectal Cancer Treated With Regorafenib: The TOREADOR Study 2.132
Primi dati paleobiologici sugli individui rinvenuti all’interno della Tomba 3 del sito di Cap de Forma (Minorca) 2.041
From central to sentral (Serum angiogenesis central): Circulating predictive biomarkers to anti-VEGFR therapy 1.923
Immunotherapy and Cancer: The Multi-Omics Perspective 1.648
Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment 1.384
Molecular-driven treatment for biliary tract cancer: the promising turning point 1.244
The burials of San Giuliano church (Selargius, Sardinia): preliminary data 1.195
The paleopathological collection of Cagliari University: case studies and future proposal 1.183
Neoadjuvant chemo-radiotherapy response in patients affected by mismatch repair deficient (dMMR) locally advanced rectal cancer 1.006
New Horizons in Metastatic Colorectal Cancer: Prognostic Role of CD44 Expression 922
null 918
Circulating tumour DNA in gastrointestinal cancer in clinical practice: Just a dream or maybe not? 777
Uncovering key targets of success for immunotherapy in pancreatic cancer 742
Prediction of Response to Anti-Angiogenic Treatment for Advanced Colorectal Cancer Patients: From Biological Factors to Functional Imaging 637
Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine plus nab-paclitaxel as first-line treatment 607
Patients with early-onset metastatic colorectal cancer as an emerging distinctive clinical and molecular phenomenon 458
Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial 408
Clinical score for colorectal cancer patients with lung-limited metastases undergoing surgical resection: Meta-Lung Score 375
CD44: A New Prognostic Marker in Colorectal Cancer? 293
A new prognostic score for biliary tract cancer: a multicenter experience 238
REINVENT (REgorafenIb traNslational eValuation angiogENesis proTocol) 236
Mismatch repair proteins (MMR) expression as predictive factor in locally advanced rectal cancer 231
Early-onset colorectal cancer patients exhibit a distinct molecular fingerprint: insights from a large-scale NGS study of 1209 patients 223
Thyroid dysfunction and immune checkpoint inhibitors: Effect on survival in elderly patients 220
Navigating the Landscape of Liquid Biopsy in Colorectal Cancer: Current Insights and Future Directions 209
Fentanyl pectin nasal spray for breakthrough cancer pain treatment: a single center experience 201
Medical management of malignant bowel obstruction: our center experience 198
Overall survival and progression-free survival in metastatic colorectal cancer patients with concomitant RAS and BRAF mutations: a single center experience 184
Image analysis techniques applied on a sample of auditory ossicles from Sardinia 162
Early onset metastatic colorectal cancer: Clinical-prognostic characteristics and correlation to molecular profile 157
Clinical characteristics and outcomes in patients with early-onset locally advanced rectal cancer 157
The impact of surgical resection in early onset colorectal cancer patients with liver limited disease 156
Influence of levothyroxine concomitant treatment on treatment responses and outcomes in patients with metastatic colorectal adenocarcinoma 137
The correlation between L1CAM expression and outcomes in patients with metastatic colorectal cancer treated with first-line chemotherapy 136
Comparison between different therapeutic sequences in patients affected by metastatic pancreatic ductal adenocarcinoma 123
Lymphocyte to monocyte ratio in metastatic pancreatic ductal adenocarcinoma as a prognostic factor and its potential role in identifying a subset of patients with a favorable response to therapy 120
The interconnection between cellular metabolism and lymphocyte activation as a prognostic factor in patients affected by metastatic pancreatic ductal adenocarcinoma treated with gemcitabine and nab-paclitaxel as first line 118
Totale 44.321
Categoria #
all - tutte 59.545
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.545


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.509 0 0 0 0 157 138 104 101 191 264 292 262
2022/20233.065 345 550 482 190 225 192 144 266 177 159 213 122
2023/20242.976 121 91 97 141 251 510 469 201 159 228 358 350
2024/202515.257 3.279 5.070 916 808 433 608 442 61 113 3.263 84 180
2025/20263.994 278 248 430 342 278 289 729 385 236 375 256 148
2026/2027787 61 147 205 341 33 0 0 0 0 0 0 0
Totale 44.321